{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T07:32:01Z","timestamp":1778311921380,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.yebeh.2020.107598","type":"journal-article","created":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T16:34:15Z","timestamp":1606667655000},"page":"107598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"PA","title":["An association between resting state EEG parameters and the severity of topiramate-related cognitive impairment"],"prefix":"10.1016","volume":"114","author":[{"given":"Christopher M.","family":"Barkley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-5376","authenticated-orcid":false,"given":"Zhenhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Fieberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn E.","family":"Eberly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela K.","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilo E.","family":"Leppik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0646-0537","authenticated-orcid":false,"given":"Susan E.","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107598_b0005","first-page":"1","article-title":"Patient-focused drug development methods for benefit-risk assessments: A case study using a discrete choice experiment for antiepileptic drugs","author":"Holmes","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.yebeh.2020.107598_b0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1528-1157.2000.tb00165.x","article-title":"Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy","volume":"41","author":"Lhatoo","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107598_b0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.yebeh.2012.04.120","article-title":"The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory","volume":"24","author":"Marino","year":"2012","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107598_b0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1528-1157.2003.05402.x","article-title":"Topiramate and psychiatric adverse events in patients with epilepsy","volume":"44","author":"Mula","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107598_b0025","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1212\/01.WNL.0000165994.46777.BE","article-title":"Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers","volume":"64","author":"Meador","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107598_b0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.seizure.2015.03.013","article-title":"Rates and predictors of patient-reported cognitive side effects of antepileptic drugs: An extended follow up","volume":"29","author":"Javed","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107598_b0035","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp.69.5.636","article-title":"Effects of topiramate on cognitive function","volume":"69","author":"Thompson","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107598_b0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.yebeh.2005.01.002","article-title":"Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy","volume":"6","author":"Fritz","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107598_b0045","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.yebeh.2006.01.016","article-title":"Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate","volume":"8","author":"de Araujo Filho","year":"2006","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107598_b0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.yebeh.2007.02.007","article-title":"The influence of antiepileptic drugs on cognition: A comparison of levetiracetam with topiramate","volume":"10","author":"Gomer","year":"2007","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107598_b0055","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF02251297","article-title":"Effects of lorazepam upon recollective experience in recognition memory","volume":"110","author":"Valerie Curran","year":"1993","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107598_b0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0149-7634(85)90034-X","article-title":"The amnesic action of benzodiazipenes in man","volume":"9","author":"Lister","year":"1985","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107598_b0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00004714-198204000-00003","article-title":"Interactions between effects of caffeine and lorazepam in performance tests and self-ratings","volume":"2","author":"File","year":"1982","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107598_b0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0091-3057(92)90026-C","article-title":"Effects of lorazepam on psychomotor performance: A comparison of independent-groups and repeated-measures designs","volume":"42","author":"File","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107598_b0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1037\/1064-1297.11.1.56","article-title":"Lorazepam and scopolamine: a single dose comparison of effects on human memory and attentional processes","volume":"11","author":"Mintzer","year":"2003","journal-title":"Exp Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107598_b0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00429732","article-title":"The nature of lorazepam-induced amnesia","volume":"83","author":"Lister","year":"1984","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107598_b0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02244079","article-title":"Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood","volume":"103","author":"Valerie Curran","year":"1991","journal-title":"Psychopharmacology"},{"issue":"3-5","key":"10.1016\/j.yebeh.2020.107598_b0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/13506280143000115","article-title":"The effects of lorazepam on visual integration processes: How useful for neuroscientists?","volume":"8","author":"Giersch","year":"2001","journal-title":"Visual Cogn"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107598_b0095","first-page":"481","article-title":"Individual differences in working memory capacity predict topiramate-induced cognitive deficits","volume":"38","author":"Barkley","year":"2018","journal-title":"J Clin Pharmacol"},{"issue":"19","key":"10.1016\/j.yebeh.2020.107598_b0100","doi-asserted-by":"crossref","first-page":"11053","DOI":"10.1073\/pnas.1831638100","article-title":"Electroencephalographic signatures of attentional and cognitive default modes in spontaneous brain activity fluctuations at rest","volume":"100","author":"Laufs","year":"2003","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107598_b0105","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/0006-3223(85)90208-2","article-title":"Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder","volume":"20","author":"Buchsbaum","year":"1985","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107598_b0110","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.clinph.2003.10.025","article-title":"The interplay of lorazepam-induced brain oscillations: microstructural electromagnetic study","volume":"115","author":"Fingelkurts","year":"2004","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107598_b0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2125.1991.tb03863.x","article-title":"Effects of granisetron and lorazepam, alone and in combination, on the EEG of human volunteers.","volume":"31","author":"Link","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107598_b0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0013-4694(89)90173-9","article-title":"Quantification of benzodiazepine-induced topographic EEG changes by a computerized waveform recognition method: application of a principal components analysis","volume":"72","author":"Manmaru","year":"1989","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107598_b0125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00002826-200109000-00005","article-title":"Clinical and electroencephalographic effects of topiramate in patients with epilepsy and healthy volunteers","volume":"24","author":"Mecarelli","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2020.107598_b0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eplepsyres.2003.12.006","article-title":"Topiramate: effect on EEG interictal abnormalities and background activity in patients with epilepsy","volume":"58","author":"Placidi","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2020.107598_b0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.yebeh.2006.12.011","article-title":"Topiramate effects on the EEG and alertness in healthy volunteers: A different profile of antiepileptic drug neurotoxicity","volume":"10","author":"Salinsky","year":"2007","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107598_b0140","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1528-1167.2006.00508.x","article-title":"Distinct cognitive neurophysiologic profiles for lamotrigine and topiramate","volume":"47","author":"Smith","year":"2006","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107598_b0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/155005940303400208","article-title":"Quantitative EEG effects of topiramate","volume":"34","author":"Wang","year":"2003","journal-title":"Clin Electroencephalogr"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107598_b0150","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.neurobiolaging.2014.07.009","article-title":"Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies","volume":"36","author":"Bonanni","year":"2015","journal-title":"Neurobiol Aging"},{"issue":"58","key":"10.1016\/j.yebeh.2020.107598_b0155","first-page":"1","article-title":"Integrative EEG biomarkers predict progression to Alzheimer\u2019s disease at the MCI stage","volume":"5","author":"Poil","year":"2013","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107598_b0160","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/WNL.0000000000000034","article-title":"Predicting dementia in Parkinson\u2019s disease by combining neurophysiologic and cognitive markers","volume":"82","author":"Dubbelink","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107598_b0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jad.2010.06.021","article-title":"An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study","volume":"128","author":"Spronk","year":"2011","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107598_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10401239609149083","article-title":"EEG abnormalities before clozapine therapy predict a good clinical response to clozapine","volume":"8","author":"Pillay","year":"1996","journal-title":"Ann Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107598_b0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1142\/S0219635208001897","article-title":"EEG phenotypes predict treatment outcome to stimulants in children with ADHD","volume":"7","author":"Arns","year":"2008","journal-title":"J Int Neurosci"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107598_b0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10401230109148950","article-title":"Does EEG predict response to valproate versus lithium in patients with mania?","volume":"13","author":"Reeves","year":"2001","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.yebeh.2020.107598_b0185","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2147\/NDT.S49611","article-title":"Predicting acute side effects of stimulant medication in pediatric attention deficit\/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a continuous-performance test","volume":"9","author":"Ogrim","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.yebeh.2020.107598_b0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/NDT.S56600","article-title":"Predicting the clinical outcome of stimulant medication in pediatric attention-deficit\/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a go\/no-go test","volume":"10","author":"Ogrim","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.yebeh.2020.107598_b0195","first-page":"1","article-title":"Predicting clinical gains and side effects of stimulant medication in pediatric attention-deficit\/hyperactivity disorder by combining measures from qEEG and ERPs in a cued GO\/NOGO task","author":"Ogrim","year":"2018","journal-title":"Clin EEG Neurosci"},{"key":"10.1016\/j.yebeh.2020.107598_b0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneumeth.2003.10.009","article-title":"EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis","author":"Delorme","year":"2004","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.yebeh.2020.107598_b0205","series-title":"CleanLine EEGLAB plugin","author":"Mullen","year":"2012"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107598_b0210","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00002826-199903000-00003","article-title":"Comparison of the effects of vigatrabin, lamotrigine, and topiramate in patients with epilepsy","volume":"22","author":"Neufeld","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2020.107598_b0215","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1469-8986.2010.01173.x","article-title":"Resting EEG theta power correlates with cognitive performance in healthy older adults","volume":"48","author":"Finnegan","year":"2011","journal-title":"Psychophysiology"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107598_b0220","first-page":"1","article-title":"Alterations in resting-state activity relate to performance in a verbal recognition task","volume":"8","author":"Zunini","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020307782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020307782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:34:31Z","timestamp":1761503671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020307782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":44,"alternative-id":["S1525505020307782"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107598","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An association between resting state EEG parameters and the severity of topiramate-related cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107598"}}